Literature DB >> 27886800

Behçet's disease: How to diagnose and treat vascular involvement.

Emire Seyahi1.   

Abstract

Behçet's disease is a multisystem disorder with unknown etiology and a unique geographic distribution. The disease is characterized by recurrent skin-mucosa lesions and sight-threatening panuveitis. Vascular involvement, which is more common and more severe among males, has also equally characteristic features such as affecting mostly veins, having a significant tendency for thrombosis, and running a relapsing course. Lower extremity vein thrombosis (LEVT) is the most frequent manifestation, followed by vena cava inferior thrombosis. Pulmonary artery involvement (PAI), the most common form of arterial involvement, manifests as aneurysms and "in situ" thrombosis. PAI and Budd-Chiari syndrome are the leading causes of increased mortality. In vascular cluster, typically, several types of venous or arterial vascular involvement may accumulate in the same individual. LEVT or cerebral venous sinus thrombosis is often present in these subgroups as the first event. Immunosuppressive treatment is essential in preventing the attacks and increasing survival. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anticoagulation; Azathioprine; Behçet's disease; Lower extremity vein thrombosis; Pulmonary artery aneurysms; Thrombosis; Vasculitis; Vena cava thrombosis

Mesh:

Substances:

Year:  2016        PMID: 27886800     DOI: 10.1016/j.berh.2016.08.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  29 in total

1.  Budd-Chiari Syndrome in Behçet's Disease successfully managed with immunosuppressive and anticoagulant therapy: A case report and literature review.

Authors:  Christian Mario Amodeo Oblitas; Francisco Galeano-Valle; Neera Toledo-Samaniego; Blanca Pinilla-Llorente; Jorge Del Toro-Cervera; Arturo Álvarez-Luque; Alejandra García-García; Pablo Demelo-Rodriguez
Journal:  Intractable Rare Dis Res       Date:  2019-02

2.  Audiological and vestibular measurements in Behçet's disease.

Authors:  Ozlem Ertugrul; Ahmet Mutlu; Ilkin Zindanci; Osman Halit Cam; Levent Ozluoglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-30       Impact factor: 2.503

3.  Intracardiac thrombosis in Behçet's Disease successfully treated with immunosuppressive agents: A case of vascular pathergy phenomenon.

Authors:  Francisco Galeano-Valle; Pablo Demelo-Rodriguez; Luís Álvarez-Sala-Walther; Blanca Pinilla-Llorente; Miguel Jesús Echenagusia-Boyra; Hugo Rodriguez-Abella; Jorge Del-Toro-Cervera
Journal:  Intractable Rare Dis Res       Date:  2018-02

4.  Hemoptysis in Behçet's syndrome: from bedside to bench?

Authors:  Giovanni Maria Rossi; Giacomo Emmi; Augusto Vaglio
Journal:  Intern Emerg Med       Date:  2018-05-07       Impact factor: 3.397

Review 5.  Pediatric Behçet's disease - clinical aspects and current concepts.

Authors:  Mehmet Yıldız; Oya Köker; Amra Adrovic; Sezgin Şahin; Kenan Barut; Özgür Kasapçopur
Journal:  Eur J Rheumatol       Date:  2019-09-05

6.  Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab.

Authors:  Claudia Fabiani; Antonio Vitale; Donato Rigante; Giacomo Emmi; Giuseppe Lopalco; Jurgen Sota; Lorenzo Vannozzi; Gerardo di Scala; Silvana Guerriero; Ida Orlando; Rossella Franceschini; Marco Capozzoli; Bruno Frediani; Mauro Galeazzi; Florenzo Iannone; Gian Marco Tosi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2018-04-18       Impact factor: 2.980

Review 7.  Cardiovascular disease in patients with autoinflammatory syndromes.

Authors:  Rainer Hintenberger; Agnes Falkinger; Kathrin Danninger; Herwig Pieringer
Journal:  Rheumatol Int       Date:  2017-11-01       Impact factor: 2.631

8.  Evaluation of hearing loss and tinnitus in Behcet's disease.

Authors:  Ahmet Karadağ; Mujde Karadağ; Adem Bora; Emrullah Hayta; A Bahadır Çetin; Sevil C Doğan; Kasım Durmuş; E Elif Altuntaş
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-06-13       Impact factor: 2.503

9.  Serious Coronary Thrombosis and Pulmonary Artery Thrombosis Revealing Behçet's Disease.

Authors:  Di Liu; Wangbin Ning; Xiaoxia Zuo
Journal:  Arch Rheumatol       Date:  2018-01-29       Impact factor: 1.472

Review 10.  Behçet Disease: An Update for Dermatologists.

Authors:  Erkan Alpsoy; Burcin Cansu Bozca; Asli Bilgic
Journal:  Am J Clin Dermatol       Date:  2021-06-01       Impact factor: 7.403

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.